ARCHIVES

ODAC Reviews Post-Marketing Studies for Eight Indications

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | March 21, 2003

Download PDF Visit The Full Archive

Related Articles

ACS-Led National Cancer Dialogue Beset By Patient Mistrust, Lack Of Openness

January 21, 2000

Surgeons Responsible For Improving Their Role, CCIRC Says

July 8, 1977

Kessler Promises Cancer Patient Liaison In FDA; Considers Joint Drugs, Biologics Oncology Review

August 14, 1992

Impact Of DRGs On Clinical Research Less Than First Feared, Speakers Tell NIH Directors Meeting

June 20, 1986

Court Filing By Fisher; Board, Attacks Interim NSABP Leadership

August 12, 1994

In Brief; NCAB To Hear Report On Human Cancer Virus, Mayo Projects, Proposed FDA Regulations

February 28, 1975